Delivery Order SPE2DB25D3012-SPE2DB25FWXEV

Award Date 5/6/25
Potential Completion Date 5/7/25
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Descovy 200-25 mg tablets. The $56,135.36 firm-fixed-price contract has an ultimate completion date of January 13, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,945.79 contract is for the delivery of Descovy 200-25 mg tablets. This order is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which provides global pharmaceutical support for military healthcare...
The U.S. government awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Descovy 200-25 mg tablets. The contract, valued at $6,233.46, has a period of performance through March 20, 2024 and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $28,726.74, is for the delivery of Descovy 200-25 mg tablets. It is a firm fixed-price contract with a performance period ending on May 6, 2025. The contract is not set-aside and was awarded on May 5, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Descovy 200-25 mg tablets, a prescription medication, with a ceiling value of $15,214.08. The contract is a firm fixed-price delivery order, with an ultimate completion date of May 2, 2025. The contract is not set-aside and was awarded on May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and this...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Descovy 200-25 mg tablets. The contract has a ceiling value of $4,349.27 and a performance period ending on May 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,363.71, is for the supply of Descovy 200-25 mg tablets. The contract is a firm fixed-price, delivery order type, with an ultimate completion date of May 30, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Descovy 200-25 mg tablets, a prescription medication, with a ceiling value of $18,417.91. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Descovy 200-25 mg tablet, a pharmaceutical product. The contract has a firm fixed price of $2,842.20 and a performance period ending on May 6, 2025. The award is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Descovy 200-25 mg tablets, a prescription medication, with a ceiling value of $2,842.20 and a period of performance through April 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
  • SPE2DB25D3012
    Indefinite Delivery Contract
  • SPE2DB25D3012-SPE2DB25FWXEV
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Descovy 200-25 mg tablets. The $34,479.28 firm fixed price contract has a completion date of May 7, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. The contract is not set-aside. AmerisourceBergen, as the prime contractor, will be responsible for supplying the pharmaceutical products to support military and government healthcare programs.

Generated 8/10/25, 1:15 AM